Running more than 20 partner programmes at once meant the biotech was generating antibody screening data continuously, but every instrument workstation held its own results in isolation. Nothing moved that data anywhere else automatically, so it sat wherever it was produced until a scientist manually pulled it out.

Getting that data usable meant real manual effort. Scientists exported CSVs by hand from each instrument, then retyped plate and sequence metadata into spreadsheets so results could be shared or compared. Partners waiting on their own programme's results had to wait weeks for a consolidated report, because assembling one meant collecting exports from wherever they had landed.

Comparing performance across programmes was harder still. With more than 20 programmes each generating data on their own workstations, seeing how one candidate compared to another meant days of manual assembly pulling exports together from across the firm, work that had to be repeated every time a real comparison was needed.

We built an automated ingestion pipeline so screening data would no longer need a scientist to move it by hand. It pulls assay and sequencing outputs directly from instrument workstations into a central research data store, standardising plate, batch and sequence metadata on the way in so every programme's results land in the same consistent shape.

On top of that central store we built a partner portal, giving each of the firm's more than 20 partner programmes a place to see its own results without waiting on a manual report. Per-programme dashboards and candidate comparison views let partners and the firm's own scientists explore data directly, and downloadable datasets replace the CSVs that used to be assembled by hand.

Access was scoped from the start rather than added afterwards. Role-scoped access means each partner sees only their own programme through the portal, so consolidating data centrally did not mean exposing it more broadly than before, it just made each programme's own view immediate instead of delayed.